• Latest Posts

FDA gives Orphan Drug Designation to CellCentric multiple myeloma drug

AI program finds multiple influenza drug targets

Centogene and Lifera to form Saudi Arabian Joint Venture

Vesalius Biocapital to invest €95M in life science companies 

Small particles will deliver TB drugs to the lungs in the future

New platform cuts time engineering and selecting genome editors


UCB myasthenia gravis drug given FDA approval 

Astraveus exits stealth to advance cell and gene therapy platform

Actimed Therapeutics raises £5M to advance lead program for cancer cachexia

Laying the foundation for the future of personalized treatment?

AbbVie takes step forward in Europe with migraine drug